Cargando…

Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents

Detalles Bibliográficos
Autores principales: Kurosaki, Yuko, Takamori, Kenji, Suga, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527742/
https://www.ncbi.nlm.nih.gov/pubmed/28794572
http://dx.doi.org/10.4103/ijd.IJD_97_17
_version_ 1783252982752608256
author Kurosaki, Yuko
Takamori, Kenji
Suga, Yasushi
author_facet Kurosaki, Yuko
Takamori, Kenji
Suga, Yasushi
author_sort Kurosaki, Yuko
collection PubMed
description
format Online
Article
Text
id pubmed-5527742
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-55277422017-08-09 Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents Kurosaki, Yuko Takamori, Kenji Suga, Yasushi Indian J Dermatol Correspondence Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5527742/ /pubmed/28794572 http://dx.doi.org/10.4103/ijd.IJD_97_17 Text en Copyright: © 2017 Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Correspondence
Kurosaki, Yuko
Takamori, Kenji
Suga, Yasushi
Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents
title Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents
title_full Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents
title_fullStr Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents
title_full_unstemmed Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents
title_short Refractory Psoriasis Vulgaris with Itching Successfully Treated with the Anti-interleukin-17A Antibody Secukinumab: A Case of Secondary Failure of Other Biologic Agents
title_sort refractory psoriasis vulgaris with itching successfully treated with the anti-interleukin-17a antibody secukinumab: a case of secondary failure of other biologic agents
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527742/
https://www.ncbi.nlm.nih.gov/pubmed/28794572
http://dx.doi.org/10.4103/ijd.IJD_97_17
work_keys_str_mv AT kurosakiyuko refractorypsoriasisvulgariswithitchingsuccessfullytreatedwiththeantiinterleukin17aantibodysecukinumabacaseofsecondaryfailureofotherbiologicagents
AT takamorikenji refractorypsoriasisvulgariswithitchingsuccessfullytreatedwiththeantiinterleukin17aantibodysecukinumabacaseofsecondaryfailureofotherbiologicagents
AT sugayasushi refractorypsoriasisvulgariswithitchingsuccessfullytreatedwiththeantiinterleukin17aantibodysecukinumabacaseofsecondaryfailureofotherbiologicagents